Respiratory Infections News

As an outpatient treatment for COVID-19, the antivirals Paxlovid and Lagevrio were both associated with reduced mortality rates, but only Paxlovid was associated with a reduction in hospitalization, data show.

Transplant medicine and the field of transplant infectious diseases have faced numerous disruptions and challenges during the COVID-19 pandemic, according to experts.

Among more than 72,000 blood donors in the United States aged 16 years or older, 96% had antibodies against the virus that causes COVID-19 by late last year, according to a new analysis.

President Joe Biden is set to announce former North Carolina secretary of health Mandy K. Cohen, MD, MPH, as the next director of the CDC, according to multiple reports.

The FDA this week approved Pfizer’s respiratory syncytial virus vaccine for adults aged 60 years or older — the second RSV vaccine approved for this population in the last month.

Researchers found that patients hospitalized withCOVID-19 received antibiotics for potential secondary bacterial infections without clinical indications suggesting they could benefit from the treatment.

Using artificial intelligence for patient triaging has the potential to streamline health care services while also tackling issues like antibiotic resistance, according to researchers.

Global data indicate that some common influenza symptoms increase with age as others decrease, researchers found.

Incidence of myocarditis/pericarditis among veterans was low across more than 10 million doses of messenger RNA COVID-19 vaccines, given as a primary or booster dose, administered at the Veterans Health Administration, researchers found.

Researchers created a symptom-based scoring system that may help diagnose long COVID more easily. The scoring system is based on 12 common symptoms identified in a study that included almost 10,000 participants.